Filtros de búsqueda

Lista de obras de

Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

artículo científico publicado en 2019

Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice

artículo científico publicado en 2019

In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer

artículo científico publicado en 2020

Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma

artículo científico publicado en 2017

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

scientific article published on 31 July 2019

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

scientific article published in 2022

Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland

scientific article published on June 2016

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

artículo científico publicado en 2022

Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin

scientific article published on 23 August 2019

Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer.

artículo científico publicado en 2015

TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development

artículo científico publicado en 2019

Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547

artículo científico publicado en 2018

Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms

artículo científico publicado en 2020

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

artículo científico publicado en 2022

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda